Detalhe da pesquisa
1.
Design of a Randomized Controlled Trial for Ebola Virus Disease Medical Countermeasures: PREVAIL II, the Ebola MCM Study.
J Infect Dis
; 213(12): 1906-13, 2016 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26908739
2.
State-of-the-Art Workshops on Medical Countermeasures Potentially Available for Human Use Following Accidental Exposures to Ebola Virus.
J Infect Dis
; 212 Suppl 2: S84-90, 2015 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25957962
3.
An open-label phase 1 clinical trial of the anti-α4ß7 monoclonal antibody vedolizumab in HIV-infected individuals.
Sci Transl Med
; 11(509)2019 09 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31488581
4.
Inferiority of IL-2 alone versus IL-2 with HAART in maintaining CD4 T cell counts during HAART interruption: a randomized controlled trial.
AIDS
; 23(2): 203-12, 2009 Jan 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-19098490
5.
Interleukin-2 cycling causes transient increases in high-sensitivity C-reactive protein and D-dimer that are not associated with plasma HIV-RNA levels.
AIDS
; 23(15): 2015-9, 2009 Sep 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-19617815